Your browser doesn't support javascript.
loading
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials.
Ratitch, Bohdana; Rodriguez-Chavez, Isaac R; Dabral, Abhishek; Fontanari, Adriano; Vega, Julio; Onorati, Francesco; Vandendriessche, Benjamin; Morton, Stuart; Damestani, Yasaman.
Afiliação
  • Ratitch B; Statistics and Data Insights, Bayer, Westmount, Québec, Canada.
  • Rodriguez-Chavez IR; Strategy Center for Decentralized Clinical Trials and Digital Medicine, Drug Development Solutions, ICON plc, Blue Bell, Pennsylvania, USA.
  • Dabral A; Global Development Operations, Amgen Inc., Thousand Oaks, California, USA.
  • Fontanari A; Product, PatchAi S.r.l., an Alira Health Company, Padua, Italy.
  • Vega J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Onorati F; Applied Data Science, Current Health, A Best Buy Health Company, Boston, Massachusetts, USA.
  • Vandendriessche B; Byteflies, Antwerp, Belgium & Department of Electrical, Computer and Systems Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
  • Morton S; Emerging Digital Medicines, Eli Lilly & Co., Indianapolis, Indiana, USA.
  • Damestani Y; Digital Medicine, Karyopharm Therapeutics, Newton, Massachusetts, USA.
Digit Biomark ; 6(3): 83-97, 2022.
Article em En | MEDLINE | ID: mdl-36466953

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Digit Biomark Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Digit Biomark Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá
...